WallStSmart
IFRX

InflaRx N.V.

NASDAQ: IFRX · HEALTHCARE · BIOTECHNOLOGY

$1.98
+18.56% today

Updated 2026-04-29

Market cap
$116.39M
P/E ratio
P/S ratio
3,968.21x
EPS (TTM)
$-0.80
Dividend yield
52W range
$1 – $2
Volume
0.8M

InflaRx N.V. (IFRX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$0.00$0.00$231000.00$0.00$0.00$0.00$0.00$0.00$63089.00$165789.00$28173.00
Revenue growth (YoY)-100.0%+162.8%-83.0%
Cost of revenue$40832.00$35658.00$66691.00$179570.00$742247.00$812474.00$791258.00$627008.00$532262.00$3.32M$7.38M
Gross profit$-40832.00$-35658.00$164309.00$-179570.00$-742247.00$-812474.00$-791258.00$-627008.00$-469173.00$-3.15M$-7.36M
Gross margin71.1%-743.7%-1900.8%-26108.5%
R&D$3.48M$5.28M$14.41M$25.03M$49.72M$29.10M$42.05M$39.37M$41.02M$35.36M$24.71M
SG&A$438000.00$1.84M$5.14M$12.79M$12.50M$8.47M$11.98M$14.87M$14.22M$15.29M$17.56M
Operating income$-3.78M$-6.89M$-19.45M$-37.52M$-63.89M$-38.93M$-56.36M$-55.07M$-44.91M$-53.01M$-48.91M
Operating margin-8417.7%-71182.1%-31973.7%-173594.0%
EBITDA$-3.82M$-7.07M$-19.58M$-42.97M$-58.84M$-37.90M$-53.11M$-30.31M$-42.06M$-45.55M$-48.50M
EBITDA margin-8476.2%-66674.3%-27476.7%-172163.8%
EBIT$-3.86M$-7.10M$-19.65M$-43.15M$-59.58M$-38.71M$-53.90M$-30.94M$-42.63M$-46.04M$-48.91M
Interest expense$1.06M$1.84M$2.23M$0.00$22200.00$26000.00$24769.00$45250.00$35628.00$20655.00$37690.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-4.92M$-8.94M$-24.24M$-29.82M$-59.61M$-38.74M$-53.93M$-30.99M$-42.67M$-46.06M$-43.83M
Net income growth (YoY)-81.8%-171.1%-23.0%-99.9%+35.0%-39.2%+42.5%-37.7%-8.0%+4.8%
Profit margin-10492.6%-67630.7%-27785.0%-155584.2%